View Exam | PowerPak

1. The GAPP-2 study (Global Attitudes of Patients and Physicians in Insulin Therapy) found that the five most common reasons for omitting insulin were: too busy; travelling; skipped meals; stress/emotional problems; public embarrassment. As defined in GAPP-2, these reasons are examples of?

A. Intentional nonadherence B. Lack of persistence C. Noncompliance D. Non-intentional nonadherence

2. A patient did not take her insulin because she feared hypoglycemia. This is an example of?

A. Intentional nonadherence B. Lack of persistence C. Noncompliance D. Non-intentional nonadherence

3. Motivational interviewing is a method to improve patient adherence. Which of the following is an example of an approach consistent with motivational interviewing?

A. Adopting the patients' cultural beliefs B. Asking the patient what is their biggest challenge with their diabetes care C. Confirming that if the patient is nonadherent, they are at risk of diabetes-related complications D. Using simple yes or no questions

4. Medication therapy management includes all of the following EXCEPT?

A. Asking patients about adverse reactions and making recommendations to decrease them B. Asking patients what they know about insulin therapy C. Providing suggestions to remember scheduled doses D. Identifying drug-drug interactions and duplication in therapy

5. Insulin therapy is the most appropriate therapy for a pharmacist to recommend to the physician for a patient who?

A. Wants to lose weight B. Is afraid of hypoglycemia C. Has an A1c of 9.5% with symptoms D. Likes to exercise rigorously but will not check home blood sugars

6. Which of the following are features of GLP-1 receptor agonists that might lead you to recommend them to physicians for certain patients?

A. Primarily targeting fasting glucose levels B. Oral therapy with good tolerability C. Rapid weight loss in every patient D. Similar glucose-lowering efficacy to basal insulin therapy alone with lower hypoglycemia risks

7. Medication therapy management can assist in improving aspects of adherence related to all of the following EXCEPT for?

A. “Best” timing for taking medicine(s) B. Decreasing some adverse effects C. Increasing patient decisional conflict(s) D. Remembering to take medicine(s)

8. Which of the following is a suggestion for overcoming resistance to injectable therapy that may help facilitate patient adherence?

A. Let the patient know that insulin injections are similar to blood glucose testing B. Recommend a basal bolus regimen of insulin C. Remind patients how well insulin has worked for their grandparents, especially when working with immigrant populations D. Recommend an insulin pen delivery device versus vial and syringe

9. Which of the following attributes associated with injectable antihyperglycemic agents would be important to discuss with physicians when patient adherence is a concern?

A. Agents with lower risks of weight gain B. Agents with lower risks of hypoglycemia C. Agents with less dosing complexity D. All of the above

10. All of the following are true about medication therapy management (MTM) EXCEPT for:

A. MTM addresses medication-related problems B. MTM ensures that medications prescribed are covered by the patients insurance C. MTM provides one-on-one communication with the patient D. MTM verifies what medications the patient is taking

Maintenance is scheduled for 05/16/2024 5:00 PM EST - 05/17/2024 5:00 AM EST.

{{recommendationsA.Title}}

{{recommendationsB.Title}}

1. The GAPP-2 study (Global Attitudes of Patients and Physicians in Insulin Therapy) found that the five most common reasons for omitting insulin were: too busy; travelling; skipped meals; stress/emotional problems; public embarrassment. As defined in GAPP-2, these reasons are examples of?

2. A patient did not take her insulin because she feared hypoglycemia. This is an example of?

3. Motivational interviewing is a method to improve patient adherence. Which of the following is an example of an approach consistent with motivational interviewing?

4. Medication therapy management includes all of the following EXCEPT?

5. Insulin therapy is the most appropriate therapy for a pharmacist to recommend to the physician for a patient who?

6. Which of the following are features of GLP-1 receptor agonists that might lead you to recommend them to physicians for certain patients?

7. Medication therapy management can assist in improving aspects of adherence related to all of the following EXCEPT for?

8. Which of the following is a suggestion for overcoming resistance to injectable therapy that may help facilitate patient adherence?

9. Which of the following attributes associated with injectable antihyperglycemic agents would be important to discuss with physicians when patient adherence is a concern?

10. All of the following are true about medication therapy management (MTM) EXCEPT for:

« Return to Activity

Maintenance is scheduled for 05/16/2024 5:00 PM EST - 05/17/2024 5:00 AM EST.

The shopping cart is empty

Customers who Purchasedthis Activity also Purchased

{{recommendationsA.Title}}

{{recommendationsB.Title}}

1. The GAPP-2 study (Global Attitudes of Patients and Physicians in Insulin Therapy) found that the five most common reasons for omitting insulin were: too busy; travelling; skipped meals; stress/emotional problems; public embarrassment. As defined in GAPP-2, these reasons are examples of?

2. A patient did not take her insulin because she feared hypoglycemia. This is an example of?

3. Motivational interviewing is a method to improve patient adherence. Which of the following is an example of an approach consistent with motivational interviewing?

4. Medication therapy management includes all of the following EXCEPT?

5. Insulin therapy is the most appropriate therapy for a pharmacist to recommend to the physician for a patient who?

6. Which of the following are features of GLP-1 receptor agonists that might lead you to recommend them to physicians for certain patients?

7. Medication therapy management can assist in improving aspects of adherence related to all of the following EXCEPT for?

8. Which of the following is a suggestion for overcoming resistance to injectable therapy that may help facilitate patient adherence?

9. Which of the following attributes associated with injectable antihyperglycemic agents would be important to discuss with physicians when patient adherence is a concern?

10. All of the following are true about medication therapy management (MTM) EXCEPT for:

« Return to Activity

Customers who Purchased
this Activity also Purchased